Collegium enters $50M accelerated share repurchase under $100M buyback program

COLLEGIUM PHARMACEUTICAL, INC

$50 million ASR agreement with Jefferies LLC; initial delivery of ~1.7M shares (80% of expected) based on $23.49 close
Final settlement expected in Q4 2023 based on volume-weighted average price during term
Part of $100M share repurchase program authorized by Board in January 2023
As of June 30, 2023, approximately 34.7 million shares outstanding

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.